Discover 1,567 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,567
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: New York NY, Hackensack NJ, The Bronx NY, New Hyde NY,
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 0+
Code: NCT01351545
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
for
Atrial Fibrillation
Location: New York NY, Staten Island NY, Hackensack NJ, Queens NY,
Sponsor: Johns Hopkins University
Sex: All
Age: 22 - 70+
Code: NCT05836987
Phase3, Recruiting
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
for
Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF),
Location: New York NY, Morristown NJ, Boston MA, Cincinnati OH,
Sponsor: Cytokinetics
Sex: All
Age: 40 - 70+
Code: NCT06793371
Phase2, Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
for
Heart Failure
Location: New York NY, The Bronx NY, Somerset NJ, Bridgewater NJ,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06424288
Phase3, Recruiting
Transcatheter Mitral Valve Replacement With the Medtronic Intrepidâ„¢ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
for
Mitral Valve Regurgitation
Location: New York NY, Manhasset NY, Roslyn NY, Morristown NJ,
Sponsor: Medtronic Cardiovascular
Sex: All
Age: 18+
Code: NCT03242642
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Location: New York NY, Manhasset NY, New Brunswick NJ, Hamden CT,
Sponsor: Vedanta Biosciences, Inc.
Sex: All
Age: 12+
Code: NCT06237452
Phase3, Recruiting
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
for
Proteinuric Kidney Disease
Location: New York NY, Brooklyn NY, Newark NJ, Hackensack NJ,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 10 - 65
Code: NCT05312879
Phase2, Phase3, Recruiting
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
for
Advanced Breast Cancer
Location: New York NY, Mineola NY, Stony Brook NY, Camden NJ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06380751
Phase3, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: New York NY, Eatontown NJ, Media PA, New Britain CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase3, Recruiting
I-DECIDE After Bronchiolitis Hospitalization
for
Bronchiolitis Acute
Location: New York NY, Hackensack NJ, The Bronx NY,
Sponsor: Seattle Children's Hospital
Sex: All
Age: 0 - 2
Code: NCT07243652
Recruiting
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
Location: New York NY, Newark NJ, Hackensack NJ, The Bronx NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT06368817
Phase2, Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: New York NY, Hackensack NJ, Mineola NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06824467
Phase3, Recruiting
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: New York NY, Brooklyn NY, The Bronx NY, Mineola NY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06500481
Phase3, Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: New York NY, Newark NJ, Hackensack NJ, New Hyde Park NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT06401330
Phase3, Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: New York NY, The Bronx NY, Mineola NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase3, Recruiting
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
for
Acute Adult T-Cell Leukemia/Lymphoma,
Location: New York NY, Mineola NY, Montvale NJ, Uniondale NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04301076
Phase1, Recruiting
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
for
Astrocytoma, IDH-Mutant, Grade 3
Location: New York NY, Brooklyn NY, Hackensack NJ,